RESUMO
IN BRIEF After assessing patient perspectives on the success of current diabetes therapies and the factors that have the greatest impact on daily life, we show that time-in-range is a crucial outcome for people with diabetes and that current therapies are falling short on this metric. We also show that patients feel significant stress and worry, and they believe they are falling short in diet, exercise, and weight maintenance. In addition, they believe diet and exercise and in-range blood glucose are the biggest drivers of improved diabetes management and mindset. Together, these findings support the need for therapies that improve outcomes including and beyond A1C.
RESUMO
Sleep can be altered by an organism's previous experience. For instance, female Drosophila melanogaster experience a post-mating reduction in daytime sleep that is purportedly mediated by sex peptide (SP), one of many seminal fluid proteins (SFPs) transferred from male to female during mating. In the present study, we first characterized this mating effect on sleep more fully, as it had previously only been tested in young flies under 12h light/12h dark conditions. We found that mating reduced sleep equivalently in 3-day-old or 14-day-old females, and could even occur in females who had been mated previously, suggesting that there is not a developmental critical period for the suppression of sleep by mating. In conditions of constant darkness, circadian rhythms were not affected by prior mating. In either constant darkness or constant light, the sleep reduction due to mating was no longer confined to the subjective day but could be observed throughout the 24-hour period. This suggests that the endogenous clock may dictate the timing of when the mating effect on sleep is expressed. We recently reported that genetic elimination of SP only partially blocked the post-mating female siesta sleep reduction, suggesting that the effect was unlikely to be governed solely by SP. We found here that the daytime sleep reduction was also reduced but not eliminated in females mated to mutant males lacking the vast majority of SFPs. This suggested that SFPs other than SP play a minimal role in the mating effect on sleep, and that additional non-SFP signals from the male might be involved. Males lacking sperm were able to induce a normal initial mating effect on female sleep, although the effect declined more rapidly in these females. This result indicated that neither the presence of sperm within the female reproductive tract nor female impregnation are required for the initial mating effect on sleep to occur, although sperm may serve to prolong the effect. Finally, we tested for contributions from other aspects of the mating experience. NorpA and eya2 mutants with disrupted vision showed normal mating effects on sleep. By separating males from females with a mesh, we found that visual and olfactory stimuli from male exposure, in the absence of physical contact, could not replicate the mating effect. Further, in ken/barbie male flies lacking external genitalia, courtship and physical contact without ejaculation were also unable to replicate the mating effect. These findings confirmed that the influence of mating on sleep does in fact require male/female contact including copulation, but may not be mediated exclusively by SP transfer.
Assuntos
Ritmo Circadiano/fisiologia , Drosophila melanogaster/fisiologia , Comportamento Sexual Animal/fisiologia , Sono/fisiologia , Fatores Etários , Análise de Variância , Animais , Animais Geneticamente Modificados , Ritmo Circadiano/genética , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Proteínas de Drosophila/genética , Proteínas de Drosophila/metabolismo , Drosophila melanogaster/genética , Feminino , Genótipo , Masculino , Mutação/genética , Fosfolipase C beta/genética , Fosfolipase C beta/metabolismo , Proteínas Tirosina Fosfatases/genética , Proteínas Tirosina Fosfatases/metabolismo , Sono/genética , Transtornos do Sono-Vigília/genética , Transtornos do Sono-Vigília/fisiopatologiaRESUMO
Payal H. Marathe, Abigail E. Dove, and Kelly L. Close are of Close Concerns (http://www.closeconcerns.com), a healthcare information company focused exclusively on diabetes and obesity care. Close Concerns publishes Closer Look, a periodical that brings together news and insights in these areas. Each month, the Journal of Diabetes includes this News feature, in which Marathe, Dove, and Close review the latest developments relevant to researchers and clinicians.
Assuntos
Congressos como Assunto , Diabetes Mellitus , Endocrinologia/organização & administração , Sociedades Médicas/organização & administração , California , Congressos como Assunto/organização & administração , Congressos como Assunto/normas , Diabetes Mellitus/patologia , Diabetes Mellitus/terapia , Drogas em Investigação/uso terapêutico , Endocrinologia/normas , Humanos , Ensaios Clínicos Controlados Aleatórios como Assunto/métodos , Sociedades Médicas/normas , Estados UnidosRESUMO
Abigail E. Dove, Payal H. Marathe, Helen X. Gao, and Kelly L. Close are of Close Concerns (http://www.closeconcerns.com), a healthcare information company focused exclusively on diabetes and obesity care. Close Concerns publishes Closer Look, a periodical that brings together news and insights in these areas. Each month, the Journal of Diabetes includes this News feature, in which Dove, Marathe, Gao, and Close review the latest developments relevant to researchers and clinicians.
Assuntos
Endocrinologia , Sociedades Médicas , Humanos , Estados UnidosAssuntos
Congressos como Assunto , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus/tratamento farmacológico , Compostos Benzidrílicos/uso terapêutico , Quimioterapia Combinada , Exenatida , Peptídeos Semelhantes ao Glucagon/uso terapêutico , Glucosídeos/uso terapêutico , Humanos , Hipoglicemiantes/uso terapêutico , Peptídeos/uso terapêutico , Resultado do Tratamento , Peçonhas/uso terapêuticoAssuntos
Compostos Benzidrílicos/uso terapêutico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Glucosídeos/uso terapêutico , Liraglutida/uso terapêutico , Estado Pré-Diabético/prevenção & controle , Redução de Peso/efeitos dos fármacos , Doenças Cardiovasculares/complicações , Doenças Cardiovasculares/prevenção & controle , Congressos como Assunto , Diabetes Mellitus Tipo 2/complicações , Humanos , Hipoglicemiantes/uso terapêutico , Estado Pré-Diabético/fisiopatologia , Qualidade de Vida , Resultado do TratamentoRESUMO
Female Drosophila melanogaster, like many other organisms, exhibit different behavioral repertoires after mating with a male. These postmating responses (PMRs) include increased egg production and laying, increased rejection behavior (avoiding further male advances), decreased longevity, altered gustation and decreased sleep. Sex Peptide (SP), a protein transferred from the male during copulation, is largely responsible for many of these behavioral responses, and acts through a specific circuit to induce rejection behavior and alter dietary preference. However, less is known about the mechanisms and neurons that influence sleep in mated females. In this study, we investigated postmating changes in female sleep across strains and ages and on different media, and report that these changes are robust and relatively consistent under a variety of conditions. We find that female sleep is reduced by male-derived SP acting through the canonical sex peptide receptor (SPR) within the same neurons responsible for altering other PMRs. This circuit includes the SPSN-SAG neurons, whose silencing by DREADD induces postmating behaviors including sleep. Our data are consistent with the idea that mating status is communicated to the central brain through a common circuit that diverges in higher brain centers to modify a collection of postmating sensorimotor processes.